Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Galaxy Therapeutics Inc. maintains 2 pending office actions within the Medical Devices & Mechanical Engineering technology area. While these actions are handled by 2 distinct examiners, they are both located within 1 distinct art unit. This concentration in a single art unit may allow for a more unified prosecution strategy, even though the company must navigate the specific preferences of different individuals. The shared 1 distinct art unit suggests that the underlying technology is closely related.
KHANDKER, RAIHAN R is the busiest examiner for the portfolio, with 1 busiest examiner pending action. Since there are 2 pending office actions and 2 distinct examiners, each examiner is managing a single case, resulting in a distributed workload. This arrangement means that the company's progress is not overly reliant on any single examiner's timeline. However, the practitioner should watch for consistent application of prior art across the 2 pending office actions, as the examiners likely share resources within the same art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KHANDKER, RAIHAN R | 1 | 64.2% | +57.2% |
| MENDEZ, KATHERINE H | 1 | 66.8% | +33.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18827606 | SYSTEM FOR AND METHOD OF TREATING ANEURYSMS | MENDEZ, KATHERINE H | 2d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18827606 | SYSTEM FOR AND METHOD OF TREATING ANEURYSMS | MENDEZ, KATHERINE H | 2d overdue |
| 18972724 | SYSTEMS AND METHODS FOR TREATING ANEURYSMS | KHANDKER, RAIHAN R | — |
| Art Unit | Apps |
|---|---|
| 3771 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18972724 | SYSTEMS AND METHODS FOR TREATING ANEURYSMS | KHANDKER, RAIHAN R | 3771 | §103 | Final Rejection | — | Pending | Dec 06, 2024 |
| 18827606 | SYSTEM FOR AND METHOD OF TREATING ANEURYSMS | MENDEZ, KATHERINE H | 3771 | §102§103 | Final Rejection | 2d overdue | Pending | Sep 06, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial